Revance Therapeutics, Inc.
RVNCDelisted Feb 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479290
Revance Therapeutics, Inc. was delisted on Feb 6, 2025; its insiders filed their last Form 4 on Feb 6, 2025; 174 institutions reported holding it in 13F filings for Q4 2024, worth $249.2M in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Revance Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 193
- +13 vs. Q3 2022
- Shares held
- 73.8M
- +6.21M (+9.2%) vs. Q3 2022
- Total value
- $1.36B
- −$460.7M (−25.3%) vs. Q3 2022
- New holders
- 38
- 79 more added
- Sold out
- 25
- 52 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVNC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $425.0K |
| Q4 2024 | 174 | $249.2M |
| Q3 2024 | 201 | $429.9M |
| Q2 2024 | 173 | $209.3M |
| Q1 2024 | 188 | $409.4M |
| Q4 2023 | 193 | $636.4M |
| Q3 2023 | 187 | $893.1M |
| Q2 2023 | 215 | $2.07B |
| Q1 2023 | 217 | $2.46B |
| Q4 2022 | 193 | $1.36B |
| Q3 2022 | 182 | $1.82B |
| Q2 2022 | 161 | $774.3M |
| Q1 2022 | 156 | $1.06B |
| Q4 2021 | 151 | $864.7M |
| Q3 2021 | 159 | $1.53B |
| Q2 2021 | 161 | $1.60B |
| Q1 2021 | 149 | $1.53B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Revance Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −85,000−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −84,259−100.0% | Sold out |
| HealthCor Management, L.P. | 0 | $0 | 0.00% | −64,590−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −63,279−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −45,800−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −41,253−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −32,735−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −20,619−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −17,642−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −10,150−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −9,907−100.0% | Sold out |
| Exencial Wealth Advisors, LLC | 0 | $0 | 0.00% | −9,045−100.0% | Sold out |
| Kingsview Wealth Management, LLC | 0 | $0 | 0.00% | −8,982−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |
| Mark Sheptoff Financial Planning, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −539−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| FourThought Financial, LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |